Pages that link to "Q48163589"

The following pages link to Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy (Q48163589):

Displaying 47 items.

• Activation of sulfonate ester based matrix metalloproteinase proinhibitors by hydrogen peroxide (Q33737922) (← links)
• Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease (Q33813567) (← links)
• Enzymatic activation of a matrix metalloproteinase inhibitor (Q33839227) (← links)
• Selective removal of copper(II) from natural waters by nanoporous sorbents functionalized with chelating diamines (Q34067084) (← links)
• Advances in iron chelation: an update (Q34174307) (← links)
• Design of small molecules that target metal-A{beta} species and regulate metal-induced A{beta} aggregation and neurotoxicity. (Q34438376) (← links)
• Synthetic Flavonoids, Aminoisoflavones: Interaction and Reactivity with Metal-Free and Metal-Associated Amyloid-β Species (Q34441109) (← links)
• Synthesis, characterization and reactivity of carbohydrate platinum(IV) complexes with thioglycoside ligands (Q35146585) (← links)
• Reactivity of diphenylpropynone derivatives toward metal-associated amyloid-β species (Q36598558) (← links)
• Application of metal coordination chemistry to explore and manipulate cell biology (Q37387617) (← links)
• Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease (Q37559812) (← links)
• Novel drug targets based on metallobiology of Alzheimer's disease. (Q37799838) (← links)
• The potential application of iron chelators for the treatment of neurodegenerative diseases. (Q37846107) (← links)
• Werner coordination chemistry and neurodegeneration (Q38041053) (← links)
• Metal complexes designed to bind to amyloid-β for the diagnosis and treatment of Alzheimer's disease (Q38199617) (← links)
• Ultraviolet light triggers the conversion of Cu2+-bound Aβ42 aggregates into cytotoxic species in a copper chelation-independent manner (Q38836859) (← links)
• Sialic Acid Hydroxamate: A Potential Antioxidant and Inhibitor of Metal-Induced β-Amyloid Aggregates (Q38878706) (← links)
• Small bifunctional chelators that do not disaggregate amyloid β fibrils exhibit reduced cellular toxicity (Q38946116) (← links)
• Thioflavin-based molecular probes for application in Alzheimer's disease: from in silico to in vitro models (Q38946925) (← links)
• 3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents (Q39100957) (← links)
• The effect of Cu(2+) and Zn(2+) on the Aβ42 peptide aggregation and cellular toxicity (Q39101514) (← links)
• Carbohydrate-conjugate heterobimetallic complexes: synthesis, DNA binding studies, artificial nuclease activity and in vitro cytotoxicity (Q39447819) (← links)
• Palladium Complexes Affect the Aggregation of Human Prion Protein PrP106-126 (Q39556302) (← links)
• In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease (Q39747442) (← links)
• Small molecule modulators of copper-induced Abeta aggregation (Q39781515) (← links)
• Sequence Determination of a Novel Tripeptide Isolated from the Young Leaves of Azadirachta indica A. Juss (Q41500778) (← links)
• Bifunctional compounds for controlling metal-mediated aggregation of the aβ42 peptide (Q42040291) (← links)
• How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study. (Q42363354) (← links)
• Multi-target-directed phenol-triazole ligands as therapeutic agents for Alzheimer's disease (Q42367176) (← links)
• Glucosylated Deferiprone and Its Brain Uptake: Implications for Developing Glucosylated Hydroxypyridinone Analogues Intended to Cross the Blood−Brain Barrier (Q42946883) (← links)
• Neuroprotective Role of a Novel Copper Chelator against Aβ 42 Induced Neurotoxicity (Q42958683) (← links)
• Supramolecular assembly of carbohydrate-functionalized salphen-metal complexes (Q43245929) (← links)
• Mutual interference of Cu and Zn ions in Alzheimer's disease: perspectives at the molecular level. (Q45327210) (← links)
• New Hydroxyquinoline-Based Derivatives as Potent Modulators of Amyloid-β Aggregations (Q46571812) (← links)
• Coordination Chemistry of Bifunctional Chemical Agents Designed for Applications in 64Cu PET Imaging for Alzheimer's Disease (Q46924077) (← links)
• Evaluation of 64Cu-Based Radiopharmaceuticals that Target Aβ Peptide Aggregates as Diagnostic Tools for Alzheimer's Disease. (Q47105084) (← links)
• Modulation of (14) C-labeled glucose metabolism by zinc during aluminium induced neurodegeneration (Q48212717) (← links)
• A bioinorganic view of Alzheimer's disease: when misplaced metal ions (re)direct the electrons to the wrong target (Q48280428) (← links)
• Iron exposure modifies acetylcholinesterase activity in zebrafish (Danio rerio) tissues: distinct susceptibility of tissues to iron overload. (Q53315604) (← links)
• Histidine-rich branched peptides as Cu(II) and Zn(II) chelators with potential therapeutic application in Alzheimer's disease. (Q53324584) (← links)
• Dual-function triazole-pyridine derivatives as inhibitors of metal-induced amyloid-β aggregation (Q57184141) (← links)
• New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases (Q57811178) (← links)
• Azo-dyes based small bifunctional molecules for metal chelation and controlling amyloid formation (Q57826116) (← links)
• Cu selective chelators relieve copper-induced oxidative stress (Q59137566) (← links)
• The study of solution equilibria in chiral capillary electrophoresis by the ligand-exchange mechanism (Q61161645) (← links)
• The chelation targeting metal–Aβ40 aggregates may lead to formation of Aβ40 oligomers (Q83709125) (← links)
• Modification of Aβ Peptide Aggregation via Covalent Binding of a Series of Ru(III) Complexes (Q92542474) (← links)